Sally Radovick, MD
Professor, Department of Pediatrics
Senior Associate Dean for Clinical and Translational Research
Robert Wood Johnson Medical School
Chancellor’s Scholar, Rutgers Biomedical and Health Sciences
Dr. Radovick is the Senior Associate Dean for Clinical and Translational Research at Rutgers-Robert Wood Johnson Medical School . In this role, she is committed to mentoring fellows and faculty in biomedical research. Dr. Radovick is a specialist in pediatric diabetes, growth, development and pubertal disorders in children. She has been involved in conducting biomedical research and mentoring students and fellows for over 25 years, mentoring over 50 graduate students, postdoctoral fellows and junior faculty and received NIH funding as a mentor for 21 post-doctoral mentees, including 6 NRSAs and 15 K01s, K08s or K23s. Additionally, the mentees received numerous private foundation training and career development awards. She also received a K24 for career development. Previously, she was the Director of the Division of Pediatric Endocrinology and the PI of the T32 Training Program in Molecular and Cellular Endocrinology at Johns Hopkins, reflecting her commitment to the goal of training. Additionally, as the Vice-Chair for Research in the Department of Pediatrics, she was the Program Director of the T32 training program for residents and fellows in Pediatrics. As the Chief of Pediatric Endocrinology at the University of Chicago, she was also the Associate Program Director for the Integrated T32 in Endocrinology at the University of Chicago. In 2004, she was awarded the first T32 in Chicago that was specifically designed to train Pediatric Endocrinologists. At Johns Hopkins University, she was director of the pilot and feasibility (P and F) core of the NIDDK Diabetes Research Center (DRC) and the NIDDK sponsored medical student summer program in diabetes research. Dr. Radovick has had extensive experience in collaborative projects having U54 and U01 awards and has been continuously supported by NIH awards since 1992. Her research deals primarily with the development and function of neuroendocrine control of mammalian growth and development. She has a broad background in physiology and molecular biology including generation of genetically engineered mice as models for human disease. Her clinical research includes studies to understand the genetic basis for short stature and determination of the appropriate dosing of metformin in children. She is a co-investigator on epidemiologic studies to determine the long term metabolic effects of premature birth.